Virus-host interactions in HIV pathogenesis: directions for therapy
- PMID: 21441474
- PMCID: PMC3144039
- DOI: 10.1177/0022034511398874
Virus-host interactions in HIV pathogenesis: directions for therapy
Abstract
The challenge of controlling HIV infection involves an understanding of the heterogeneity of the virus, its wide cellular host range, its primary routes of transmission, and the immunologic and intrinsic cellular factors that can prevent its transmission and replication. Identification of HIV-infected individuals who have survived more than 10 years without signs of the infection and without therapy encourages studies examining the natural mechanisms for resistance to infection and disease. Within the immune system, emphasis should be given to the innate or natural response that appears within minutes of the infection and offers the optimal time for controlling HIV. All these parameters in HIV pathogenesis underline the information needed to develop optimal anti-HIV therapies and an effective AIDS vaccine.
Figures


References
-
- Asjo B, Albert J, Karlsson A, Morfeldt-Manson L, Biberfeld G, Lidman K, et al. (1986). Replicative properties of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 2:660-662 - PubMed
-
- Barker E, Mackewicz CE, Reyes-Teran G, Sato A, Stranford SA, Fujimura SH, et al. (1998). Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared to those who have progressed to acquired immunodeficiency syndrome. Blood 92:3105-3114 - PubMed
-
- Berger EA, Murphy PM, Farber JM. (1999). Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 17:657-700 - PubMed
-
- Cheng-Mayer C, Seto D, Tateno M, Levy JA. (1988). Biologic features of HIV that correlate with virulence in the host. Science 240:80-82 - PubMed